RNA-binding protein LIN28B inhibits apoptosis through regulation of the AKT2/FOXO3A/BIM axis in ovarian cancer cells

Xiaojuan Lin, Jianfeng Shen, Dan Peng, Xinhong He, Congjian Xu, Xiaojun Chen, János L. Tanyi, Kathleen T. Montone, Yi Fan, Qihong Huang, Lin Zhang, Xiaomin ZhongSignal 2018 · DOI

TL;DR

This study reveals a novel mechanism by which the RNA-binding protein LIN28B promotes ovarian cancer by suppressing apoptosis. LIN28B directly binds to AKT2 mRNA, increasing AKT2 protein levels, which in turn phosphorylates FOXO3A. This cascade ultimately leads to decreased BIM transcription, a key pro-apoptotic factor, thereby promoting cancer cell survival and tumor growth.

What Problem Does This Paper Address?

Epithelial ovarian cancer remains a leading cause of gynecologic malignancy-related mortality, highlighting the urgent need to understand its underlying molecular mechanisms and identify therapeutic targets. While LIN28B has been implicated as an oncogene in various cancers, its specific role and the precise molecular pathways it manipulates in ovarian cancer remain largely unexplored. This paper aims to elucidate how LIN28B contributes to ovarian tumorigenesis by investigating its impact on apoptosis, a critical process for controlling cell proliferation and eliminating damaged cells.

Methods

The researchers employed a multi-pronged approach to unravel LIN28B's role in ovarian cancer:

  • Immunohistochemistry and Western Blotting: To assess LIN28B protein expression in patient samples and ovarian cancer cell lines.
  • RNA Interference (shRNA) and Overexpression: To manipulate LIN28B levels and observe the effects on apoptosis.
  • Annexin V Apoptosis Assay: To quantitatively measure the percentage of apoptotic cells.
  • Western Blotting for Apoptosis Markers: To detect cleaved PARP and caspases (caspase-3, -7, and -9), key indicators of apoptosis.
  • Caspase-3/7 Enzymatic Activity Assay: To directly measure the activity of key apoptotic enzymes.
  • RNA Immunoprecipitation (RIP) followed by Microarray Analysis: To identify LIN28B-bound mRNAs genome-wide, revealing its potential targets.
  • Quantitative Real-Time PCR (qRT-PCR): To validate the binding of LIN28B to specific mRNAs and to measure mRNA expression levels.
  • In vivo Xenograft Model: To assess the impact of LIN28B on tumor growth in a living organism.
  • siRNA Knockdown: To investigate the role of specific downstream targets like BIM and FOXO3A.

Datasets

  • Human Epithelial Ovarian Cancer Specimens: Two cohorts (Helsinki cohort, n=470; Penn cohort, n=114) were used for immunohistochemical analysis of LIN28B expression.
  • Ovarian Cancer Cell Lines: 26 cell lines were used for western blotting. Specific cell lines (A2780 and TOV-112D) were used for functional experiments.
  • Normal Human Organ Tissue Microarray: Used to assess LIN28B expression in healthy tissues.
  • The Cancer Genome Atlas (TCGA) Database: Used to analyze the correlation between LIN28B mRNA expression and overall survival in 582 ovarian cancer patients.

Key Insights and Ideas

  • LIN28B as a Pro-survival Oncogene in Ovarian Cancer: The study firmly establishes LIN28B as an oncogene in ovarian cancer, not by promoting proliferation directly, but by actively suppressing apoptosis. This is a crucial distinction, as it targets a fundamental mechanism of cell death.
  • The AKT2/FOXO3A/BIM Axis as a Key LIN28B Target: The paper meticulously dissects a specific molecular pathway that LIN28B manipulates. The identification of AKT2 as a direct mRNA target of LIN28B, leading to downstream effects on FOXO3A and BIM, provides a concrete mechanistic link.
  • BIM as the Critical Downstream Effector: The findings strongly suggest that BIM, a pro-apoptotic protein, is the primary mediator of LIN28B's anti-apoptotic function. LIN28B's ability to reduce BIM expression is central to its oncogenic role.
  • RNA-Binding Activity is Key: The study highlights LIN28B's function as an RNA-binding protein, directly interacting with target mRNAs to regulate their protein expression. This underscores the importance of post-transcriptional regulation in cancer.
  • Potential for Targeted Therapies: By identifying this specific axis, the research opens avenues for developing targeted therapies that could inhibit LIN28B or reactivate the AKT2/FOXO3A/BIM pathway to restore apoptosis in ovarian cancer cells.

Key Results

  • LIN28B was expressed in over half (65.5% in Helsinki, 54.4% in Penn cohort) of epithelial ovarian cancer patients and was undetectable in normal ovarian surface and fallopian tube epithelia.
  • Knocking down LIN28B significantly increased camptothecin-induced apoptosis in ovarian cancer cells, while LIN28B overexpression reduced apoptosis.
  • LIN28B knockdown led to increased expression of the pro-apoptotic factor BIM, while LIN28B overexpression decreased BIM expression at both the protein and mRNA levels.
  • RNA-IP microarray identified 1555 LIN28B-bound mRNAs, with a significant enrichment in pathways related to DNA damage and cell cycle regulation.
  • LIN28B was found to directly bind to AKT2 mRNA, enhancing AKT2 protein expression.
  • LIN28B knockdown reduced AKT2 and phospho-AKT2 protein levels, and also decreased phospho-FOXO3A, indicating a more active FOXO3A.
  • Ectopic overexpression of AKT2 or knockdown of FOXO3A could rescue BIM expression in LIN28B knockdown cells, confirming the AKT2/FOXO3A axis's role.
  • LIN28B knockdown significantly reduced tumor size in xenograft models, while LIN28B overexpression increased it.

Limitations and Future Work

  • Complexity of LIN28B's Regulatory Network: While the AKT2/FOXO3A/BIM axis is elucidated, the RNA-IP analysis revealed LIN28B binding to a large number of other mRNAs involved in various pathways, including cell cycle regulation. The full extent of LIN28B's regulatory network and its context-dependent functions across different cancer types and cellular states remain to be explored.
  • Potential Role of let-7: The discussion briefly mentions the possibility of LIN28B's involvement in the PI3-kinase/AKT pathway via let-7 repression. Further investigation into the interplay between LIN28B, let-7, and the AKT pathway would be valuable.
  • Therapeutic Strategies: The authors suggest that further functional characterization of LIN28B's downstream molecular networks will contribute to developing novel targeted therapeutic strategies. This implies a need for preclinical and clinical studies to translate these findings into effective treatments.

Summary updated

Abstract

LIN28B is an evolutionarily conserved RNA-binding protein that regulates mRNA translation and miRNA <i>let-7</i> maturation in embryonic stem cells and developing tissues. Increasing evidence demonstrates that <i>LIN28B</i> is activated in cancer and serves as a critical oncogene. However, the underlying molecular mechanisms of LIN28B function in tumorigenesis are still largely unknown. Here we report that LIN28B was expressed in over half of the patients with epithelial ovarian cancer who were examined (<i>n</i> = 584). Functional experiments demonstrated that LIN28B inhibited ovarian cancer cell apoptosis. Furthermore, we showed that the proapoptotic factor BIM played an essential role in the antiapoptotic function of LIN28B. RNA-IP microarray analysis suggested that LIN28B binds to mRNAs that are associated with the DNA damage pathway, such as <i>AKT2</i>, in ovarian cancer cells. By binding to <i>AKT2</i> mRNA and enhancing its protein expression, LIN28B regulated FOXO3A protein phosphorylation and decreased the transcriptional level of <i>BIM</i>, which antagonized the antiapoptosis activity of LIN28B. Taken together, these results mechanistically linked LIN28B and the AKT2/FOXO3A/BIM axis to the apoptosis pathway. The findings may have important implications in the diagnosis and therapeutics of ovarian cancer.
BibTeX
@inproceedings{lin2018rna,
  author = {Xiaojuan Lin and Jianfeng Shen and Dan Peng and Xinhong He and Congjian Xu and Xiaojun Chen and János L. Tanyi and Kathleen T. Montone and Yi Fan and Qihong Huang and Lin Zhang and Xiaomin Zhong},
  title = {{RNA-binding protein LIN28B inhibits apoptosis through regulation of the AKT2/FOXO3A/BIM axis in ovarian cancer cells}},
  booktitle = {Signal},
  year = {2018},
  doi = {10.1038/s41392-018-0026-5},
}
Figure